©The Author(s) 2025.
World J Gastroenterol. Feb 7, 2025; 31(5): 101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.101280
Table 2 Comorbidities of patients with gastrointestinal schwannomas (n = 229), n (%)
| Variable | Overall |
| Gastrointestinal neoplasms | |
| Esophageal leiomyoma | 1 (0.4) |
| Gastric stromal tumor | 1 (0.4) |
| Gastric adenocarcinoma | 2 (0.9) |
| Colorectal adenoma | 2 (0.9) |
| Rectal adenocarcinoma | 1 (0.4) |
| Adenoma of the appendix | 1 (0.4) |
| Other tumors | |
| Hepatocellular carcinoma | 4 (1.7) |
| Intraductal papillary mucinous tumor of the pancreas | 1 (0.4) |
| Adrenal cortical adenoma | 1 (0.4) |
| Clear cell carcinoma of the kidney | 3 (1.3) |
| Hamartoma of kidney | 1 (0.4) |
| Non-Hodgkin’s lymphoma | 1 (0.4) |
| Leukemia | 1 (0.4) |
| Ovarian adenoma | 2 (0.9) |
| Adenocarcinoma of lung | 2 (0.9) |
| Meningioma | 1 (0.4) |
| Adenocarcinoma of prostate | 1 (0.4) |
| Breast cancer | 1 (0.4) |
| Thyroid cancer | 1 (0.4) |
- Citation: Zhang PC, Wang SH, Li J, Wang JJ, Chen HT, Li AQ. Clinicopathological features and treatment of gastrointestinal schwannomas. World J Gastroenterol 2025; 31(5): 101280
- URL: https://www.wjgnet.com/1007-9327/full/v31/i5/101280.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i5.101280